Abstract: The present invention describes food supplements that contain one or more fruit extracts useful for pain relief and anti-inflammation. The food supplements may be used to inhibit inflammation mediated by cyclooxygenase and more particularly by cyclooxygenase-2.

Abstract: An air freshener device is provided which includes a portion to display cut flowers or other decorative accents, as well as an optionally-powered portion that contains fragrance and one or more of a variety of fragrance dispersal devices. The air freshener device may include an inductive charging system to allow for the device to be electrically charged and placed remotely from its charging base station relying on on-board electrical power storage. Other power sources such as AC or DC power supplies, batteries, or capacitors may also be used to power the air freshener device.

Abstract: The present invention is directed to plant based formulations for improving liver health by protecting the liver from alcohol and chemical insults and/or by inducing phase II enzymes. Formulations according to the present invention include wasabi root fiber powder, artichoke leaf extract, asparagus dehydrate, kudzu root extract, oregano extract, schisandra berry extract, notoginseng (ethanol extract of Panax notoginseng root), sanchi (water extracts from Panax notoginseng root), Gegen root extract (Pueraria omeiensis), spinach dehydrate, or combinations thereof.

Abstract: The present invention is directed to plant based formulations for improving liver health by protecting the liver from alcohol and chemical insults and/or by inducing phase II enzymes. Formulations according to the present invention include wasabi root fiber powder, artichoke leaf extract, asparagus dehydrate, kudzu root extract, oregano extract, schisandra berry extract, notoginseng (ethanol extract of Panax notoginseng root), sanchi (water extracts from Panax notoginseng root), Gegen root extract (Pueraria omeiensis), spinach dehydrate, or combinations thereof.

Abstract: The present invention relates to the use of Echinacea as a cancer chemopreventive agent to block the formation of and to detoxify cancer-causing agents, or carcinogens. More particularly, the present invention relates to the induction of phase II enzymes by Echinacea, and specifically by lipid-soluble fractions isolated from Echinacea. The present invention also contemplates a novel method of extracting the desired lipid-soluble fractions from Echinacea.

Abstract: The present invention is directed to a multi-chambered dispenser for blending and dispensing a customized liquid product such as a liquid cosmetic foundation. The dispenser includes a device for selecting a customized liquid formula; a plurality of cartridges separately containing pre-mix compositions for the customized liquid product; at least one ink jet head in fluid communication with the cartridges; a central processing unit for processing the customized liquid formula and activating the ink jet head; whereby the ink jet head dispenses the pre-mix compositions in accordance with the customized liquid formula to provide a customized liquid product.

Abstract: The present invention provides a WTS closure assembly that is easily and quickly secured to and removed from the filter chamber of a WTS. The closure assembly of the present invention provides a bail handle attached to the closure and which utilizes a mechanical advantage, preferably in the form of a pivoting handle which presses a plurality of cams onto the WTS housing, thereby breaking a seal between the closure assembly and the WTS filter chamber, and lifting the closure away from the filter chamber.

Abstract: A composition for increasing GH levels in a mammal including effective amounts of huperzine A and secretagogue amino acids and methods thereof.

Abstract: A method for distributing an equal volume of attached confluent living cells in each well of a multi-well plate used in a bioassay, comprising the following steps: (a) growing attached living cells on a medium until the cells are confluent; (b) treating the attached confluent living cells with an enzyme solution, whereby the solution and the attached confluent living cells make a cell suspension; (c) filtering the cell suspension with a filter; (d) collecting a cell suspension filtrate containing uniformly distributed attached confluent living cells therein; and (e) distributing an equal volume of the cell suspension filtrate into wells of a plate whereby each well has an equal volume of cells for use in any bioassay.